PUBLIC COMPANY

$LONALeonaBio, Inc.

Bothell, WA, USupdated 1mo ago

SEC EDGAR Yahoo Finance

community read0 votes

pipeline

3

marketed

0

phase 3

1

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(3)

pipeline depth3 products

2Phase 11Phase 3

Phase 3

lasofoxifene tartrate

Human Epidermal Growth Factor Receptor 2 Negative Breast…

Estrogen receptor

Phase 1

ATH-1020

Neurodegenerative Diseases

Phase 1

ATH-1105

Amyotrophic Lateral Sclerosis

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view LeonaBio, Inc. jobs →

News

no news has mentioned this company yet

$LONA

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

SEC EDGAR

last refreshed just now

Found something off?

Insider activity

source: SEC Form 4

open-market buys + sells

Mar 4, 26SELLLitton Mark James· PRESIDENT and CEO5,156 sh @ $5.37−$28K↗
Mar 4, 26SELLSan Martin Javier· CHIEF MEDICAL OFFICER1,720 sh @ $5.37−$9K↗
Mar 4, 26SELLCHURCH KEVIN· CHIEF SCIENTIFIC OFFICER1,359 sh @ $5.37−$7K↗
Mar 4, 26SELLWorthington Mark· GENERAL COUNSEL and CCO1,328 sh @ $5.37−$7K↗
Mar 4, 26SELLRenninger Robert· CHIEF FINANCIAL OFFICER906 sh @ $5.37−$5K↗

routine RSU / option mechanics (6)

Apr 9, 26grantJOHNSON JAMES A · 28,000 sh
Apr 9, 26grantEDELMAN JOSEPH · 28,000 sh
Apr 9, 26grantSan Martin Javier · CHIEF MEDICAL OFFICER350,000 sh
Apr 9, 26grantFLUKE JOHN M JR · 28,000 sh
Apr 9, 26grantWorthington Mark · GENERAL COUNSEL and CCO300,000 sh
Apr 9, 26

grant

Renninger Robert · CHIEF FINANCIAL OFFICER

300,000 sh